Skip to main content
Premium Trial:

Request an Annual Quote

New Bristol Interdisciplinary Unit to Study Genetics of Disease

NEW YORK (GenomeWeb News) – The University of Bristol has announced that it plans to open a new £23million ($34.8 million) epidemiological research center that will harness an array of disciplines including genetics, epigenetics, computer sciences, chemistry, psychology, and others.

Funded by the university and the UK's Medical Research Council, the new Integrative Epidemiology Unit is scheduled to launch on June 1.

The unit will emphasize using genetics to gain a better understanding of how lifestyle, environmental changes, and pharmacological treatments can lower the risk of disease.

Bristol said the effort will capitalize on major investments the university has made in new sample processing technologies to boost its ability to study the biological mechanisms of disease.

"The exponential increase in molecular data that can be generated should transform both the scope and power of epidemiological methods to improve understanding of human development and disease," Bristol Professor Davey Smith said in a statement.

Some of the new unit's research projects will be conducted within the Children of the 90s study, a long-term health project co-funded by Bristol, the MRC, and the Wellcome Trust.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.